Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Phababpha, Suphawadee ^a   Kukongviriyapan, Upa ^a   Pakdeechote, Poungrat ^a   Senggunprai, Laddawan ^a   Kukongviriyapan, Veerapol ^a   Settasatian, Chatri ^a   Tatsanavivat, Pyatat ^a   Intharaphet, Phongsak ^a   Senthong, Vichai ^a   Komanasin, Nantarat ^b   Settasatian, Nongnuch ^b   Greenwald, Stephen E ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arterial stiffness; Chromosome 9p21.3; Metabolic syndrome; Pulse wave velocity; Single nucleotide polymorphism rs1333049

Indexed keywords

ADULT; AGED; ALLELE; AORTIC ANKLE PULSE WAVE VELOCITY; AORTIC FEMORAL PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTICLE; BLOOD CHEMISTRY; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARDIOMETABOLIC RISK; CHROMOSOME 9P; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE WAVE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASE; CHROMOSOME 9; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; THAILAND;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THAILAND; VASCULAR STIFFNESS;

EID: 84879070859     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-93     Document Type: Article

References (40)

1. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010, 375(9710):181-183. 10.1016/S0140-6736(09)61794-3, 20109902.
2. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007, 7:220. 10.1186/1471-2458-7-220, 2048947, 17727697.
3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28(4):629-636. 10.1161/ATVBAHA.107.151092, 18174459.
4. Patel A, Huang KC, Janus ED, Gill T, Neal B, Suriyawongpaisal P, Wong E, Woodward M, Stolk RP. Is a single definition of the metabolic syndrome appropriate?-A comparative study of the USA and Asia. Atherosclerosis 2006, 184(1):225-232. 10.1016/j.atherosclerosis.2005.04.012, 15935356.
5. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316(5830):1488-1491. 10.1126/science.1142447, 2711874, 17478681.
6. Engelen L, Ferreira I, Gaens KH, Henry RM, Dekker JM, Nijpels G, Heine RJ, Hart LM T, Van Greevenbroek MM, Van der Kallen CJ. The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies. J Hypertens 2010, 28(2):285-293. 10.1097/HJH.0b013e3283330931, 20051912.
7. Ling Y, Li X, Gu Q, Chen H, Lu D, Gao X. A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovasc Diabetol 2011, 10:27. 10.1186/1475-2840-10-27, 3079619, 21470412.
8. Yang SJ, Lee ST, Kim WJ, Park SE, Park SW, Kim JW, Park CY. Genetic variation in CYP17A1 is associated with arterial stiffness in diabetic subjects. Exp Diabetes Res 2012, 2012:827172. 3485973, 23133444.
9. Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005, 48(10):2006-2012. 10.1007/s00125-005-1892-2, 1289275, 16079962.
10. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17(6):806-814.
11. Cannon CP. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol 2008, 102(12A):5L-9L.
12. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605. 10.1093/eurheartj/ehl254, 17000623.
13. Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW, Tse HF. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes. Cardiovasc Diabetol 2012, 11:101. 10.1186/1475-2840-11-101, 3444371, 22900680.
14. Shin JY, Lee HR, Lee DC. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 2011, 10:30. 10.1186/1475-2840-10-30, 3098149, 21492487.
15. Plichart M, Empana JP, Lambert JC, Amouyel P, Tiret L, Letenneur L, Berr C, Tzourio C, Ducimetiere P. Single polymorphism nucleotide rs1333049 on chromosome 9p21 is associated with carotid plaques but not with common carotid intima-media thickness in older adults. A combined analysis of the Three-City and the EVA studies. Atherosclerosis 2012, 222(1):187-190. 10.1016/j.atherosclerosis.2012.02.038, 22436605.
16. Bown MJ, Braund PS, Thompson J, London NJ, Samani NJ, Sayers RD. Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet 2008, 1(1):39-42. 10.1161/CIRCGENETICS.108.789727, 20031540.
17. Dandona S, Stewart AF, Chen L, Williams K, So D, O'Brien E, Glover C, Lemay M, Assogba O, Vo L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 2010, 56(6):479-486. 10.1016/j.jacc.2009.10.092, 20670758.
18. Bjorck HM, Lanne T, Alehagen U, Persson K, Rundkvist L, Hamsten A, Dahlstrom U, Eriksson P. Association of genetic variation on chromosome 9p21.3 and arterial stiffness. J Intern Med 2009, 265(3):373-381. 10.1111/j.1365-2796.2008.02020.x, 19019192.
19. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366(9491):1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882.
20. Ma WY, Li HY, Hung CS, Lin MS, Chiu FC, Lin CH, Shih SR, Chuang LM, Wei JN. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. Diabetes Res Clin Pract 2009, 85(3):335-341. 10.1016/j.diabres.2009.06.020, 19608293.
21. Detchaporn P, Kukongviriyapan U, Prawan A, Jetsrisuparb A, Greenwald SE, Kukongviriyapan V. Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients. Pediatr Cardiol 2012, 33(7):1054-1060. 10.1007/s00246-012-0225-8, 22349676.
22. Cameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol 2007, 34(7):677-682. 10.1111/j.1440-1681.2007.04659.x, 17581229.
23. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007, 211(2):157-172. 10.1002/path.2101, 17200940.
24. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008, 51(4):527-539. 10.1007/s00125-007-0918-3, 18239908.
25. Wassink AM, Olijhoek JK, Visseren FL. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 2007, 37(1):8-17. 10.1111/j.1365-2362.2007.01755.x, 17181562.
26. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis 2010, 211(2):480-485. 10.1016/j.atherosclerosis.2010.03.037, 20430390.
27. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012, 30(3):445-448. 10.1097/HJH.0b013e32834fa8b0, 22278144.
28. Sugawara J, Hayashi K, Yokoi T, Tanaka H. Age-associated elongation of the ascending aorta in adults. JACC Cardiovasc Imaging 2008, 1(6):739-748. 10.1016/j.jcmg.2008.06.010, 19356510.
29. Wenn CM, Newman DL. Arterial tortuosity. Australas Phys Eng Sci Med 1990, 13(2):67-70.
30. Youn JC, Kim JY, Park S, Kwon J, Lee HS, Shin DH, Lee SH, Kang SM, Hoon Son N, Jang Y. Comparison of arterial stiffness indices measured by the Colins and SphygmoCor systems. Hypertens Res 2012, 35(12):1180-1184. 10.1038/hr.2012.113, 22833159.
31. Deng LH, Huang R, Wu ZL, Xu DL. [Value of C-reactive protein in the diagnosis of arteriosclerosis in patients with essential hypertension]. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29(3):521-524.
32. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 2008, 52(5):378-384. 10.1016/j.jacc.2007.11.087, 18652946.
33. Horne BD, Carlquist JF, Muhlestein JB, Bair TL, Anderson JL. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet 2008, 1(2):85-92. 10.1161/CIRCGENETICS.108.793158, 2745117, 19956784.
34. Wang W, Peng W, Zhang X, Lu L, Zhang R, Zhang Q, Wang L, Chen Q, Shen W. Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients. Cardiovasc Diabetol 2010, 9:33. 10.1186/1475-2840-9-33, 2924260, 20691078.
35. Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, Hedley A, De Meyer T, Budaj A, Van de Werf F, et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. Eur Heart J 2010, 31(9):1132-1141. 10.1093/eurheartj/ehq053, 2862180, 20231156.
36. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011, 25(2):444-448. 10.1096/fj.10-172452, 20956613.
37. Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E, Bobik A. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol 2004, 24(8):1391-1396. 10.1161/01.ATV.0000133605.89421.79, 15166010.
38. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet DA, Mangino M, Linsel-Nitschke P, Cambien F, Hengstenberg C, Stark K. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008, 117(13):1675-1684. 10.1161/CIRCULATIONAHA.107.730614, 2689930, 18362232.
39. Samani NJ, Schunkert H. Chromosome 9p21 and cardiovascular disease: the story unfolds. Circ Cardiovasc Genet 2008, 1(2):81-84. 10.1161/CIRCGENETICS.108.832527, 20031549.
40. Biros E, Cooper M, Palmer LJ, Walker PJ, Norman PE, Golledge J. Association of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis 2010, 212(2):539-542. 10.1016/j.atherosclerosis.2010.06.015, 2952706, 20605023.